QHSLab, Inc. Share Price

Equities

USAQ

US90350R1077

Healthcare Facilities & Services

Market Closed - OTC Markets 20:21:57 30/04/2024 BST 5-day change 1st Jan Change
0.1194 USD +13.87% Intraday chart for QHSLab, Inc. +32.78% +32.78%
Sales 2022 1.24 99.33 Sales 2023 1.41 112.58 Capitalization 876K 70.01M
Net income 2022 -1M -79.9M Net income 2023 - 0 EV / Sales 2022 2,435,468 x
Net Debt 2022 1.5M 120M Net Debt 2023 1.73M 138M EV / Sales 2023 1,849,662 x
P/E ratio 2022
-1.48 x
P/E ratio 2023
-1.81 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 67.18%
More Fundamentals * Assessed data
Dynamic Chart
QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
QHSLab, Inc. Integrates Digital Medicine Assessments into Prominent Electronic Health Record Company CI
Earnings Flash (USAQ) QHSLAB Reports Q3 Revenue $336,407 MT
QHSLab, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
QHSLab, Inc. Welcomes Six New Integrated Service Program Customer Accounts and Launches Enhanced Website for Improved Customer Engagement CI
QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
QHSLab, Inc. Auditor Raises 'Going Concern' Doubt CI
QHSLab, Inc. Announces Representation Agreement with Healthcare Information Technology CI
QHSLab, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force CI
Qhslab, Inc. Launches A “Long Covid” Digital Health Tool for Primary Care Physicians CI
QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
QHSLab, Inc. announced that it has received $0.4 million in funding from Mercer Street Capital Partners, LLC CI
More news
1 day+13.87%
1 week+32.78%
Current month+37.51%
1 month+37.51%
3 months-33.24%
6 months+291.80%
Current year+32.78%
More quotes
1 week
0.07
Extreme 0.071
0.12
1 month
0.06
Extreme 0.061
0.12
Current year
0.04
Extreme 0.04
0.18
1 year
0.02
Extreme 0.0155
0.25
3 years
0.02
Extreme 0.0155
1.00
5 years
0.01
Extreme 0.012
1.00
10 years
0.01
Extreme 0.005
1.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 26/05/15
Investor Relations Contact - -
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Chief Executive Officer 47 26/05/15
More insiders
Date Price Change Volume
30/04/24 0.1194 +13.87% 48,001
29/04/24 0.1049 +11.01% 57,590
26/04/24 0.0945 +5.00% 37,215
24/04/24 0.09 -3.23% 8,305

Delayed Quote OTC Markets, April 30, 2024 at 08:21 pm

More quotes
QHSLab, Inc. is a medical device technology and software-as-a-service (SaaS) company. The Company focuses on enabling primary care physicians (PCPs) to increase their revenues by providing them with tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. The products that the Company provides its physician clients enables them to diagnose and treat patients with chronic diseases The Company is engaged in providing PCPs with the software, training and devices necessary that allow them to treat their patients using value-based healthcare, informatics and algorithmic personalized medicine. Its digital healthcare, clinical decision support and point of care solutions also support non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and are reimbursable to medical practice.
More about the company